Protecting Generations of Innovations

arrow

An internationally known and trusted name in IP Law

Maier & Maier was established with the goal of providing intellectual property analysis and advice for large, multi-national corporations, universities, middle-market and emerging market companies, and startups and spinouts. We are proud of our ability to advise our clients, and to obtain patent protection for a wide scale of technologies, and offer years of experience in litigation, licensing, and other intellectual property-related issues.

The History of Our Firm

Bipartisan Group of Senators Introduce “STRONGER Patents Act of 2017”

In late June, three Democratic senators (Chris Coons (D-DE), Dick Durbin (D-IL), and Mazie Hirono (D-HI)) and one Republican senator (Tom Cotton (R-AR)) introduced the “STRONGER Patents Act of 2017.” This bill appears to have been motivated by a recent report from the U.S. Chamber of Commerce that had been heavily critical of the U.S. […]

Read More »

Supreme Court Clarifies Biosimilar Legislation in Sandoz

On June 12, the Supreme Court also handed down another patent-related opinion in Amgen Inc. v. Sandoz Inc., a case dealing with the Biologics Price Competition and Innovation Act, a small 17-page subchapter contained within the Affordable Care Act (“Obamacare”). This subchapter deals with generic “biologics,” very-large-molecule drugs typically synthesized from biological sources such as […]

Read More »

Supreme Court to Review Constitutionality of Post-Grant Proceedings in Oil States

On June 12, the Supreme Court granted certiorari in Oil States vs. Greene’s Energy Group, et al., a case dealing with the constitutionality of the post-grant challenge procedures established by the America Invents Act (AIA). The Federal Circuit, below, had upheld the constitutionality of these procedures. The petition for writ of certiorari submitted by Oil […]

Read More »